Heparin Market by Product (Unfractionated Heparin,Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH)), Source(Bovineand Porcine), Application (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, and Others), Route of Administration (Intravenous and Subcutaneous), and End User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

Pages: NA
Oct 2020 | 463 Views
Author(s) : NA
Tables: NA
Charts: NA


Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Heparin Market

Request Now !

Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. Heparin is used to prevent formation of blood clots caused by certain medical conditions or medical procedures. It is used in the treatment for various health conditions such asacute coronary syndrome, deep-vein thrombosis, pulmonary embolism, atrial fibrillation, and is also used during heart surgery for carrying out cardiopulmonary by passas well as hemofiltration. Its application also includes its administration for major orthopedic surgeries such as hip replacement and knee replacement.Recent development in heparin research to develop heparin with ultra-low molecular weight for utilization in chemotherapyopened new avenues for the heparin market.


Rise in occurrence of venous thrombosis due to various underlying factors such as cardiovascular diseases drives the growth of the global heparin market. In addition, application of heparin in various surgeries such as orthopedic and heart surgeries and increase in number of patients undergoing such surgeries further boosts the growth of the market. However, many adverse side-effects associated with heparin such as heparin-induced thrombocytopenia restrains the growth of the market. In addition, as heparin is derived from animal sources, it poses a significant safety and supply issues, which further limits the growth of the market. In contrast, availability of synthetic and semi-synthetic heparin mimetics that assist in treating various cancers, coagulation, and inflammatory diseasesare anticipated to provide lucrative opportunities for the adoption of heparin products.Moreover, increase in government funding toward improving healthcare facilities and extensive research and development (R&D) activities to develop heparin with improved therapeutic potential and minimal side-effects are anticipated to further provide lucrative opportunities to the market. 

The heparin market is segmented on the basis of product, source, application, route of administration and end user. By product, the market is segmented into unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin (ULMWH). By source, the market is segmented into bovine and porcine. On the basis of application, the market is segmented into venous thromboembolism, atrial fibrillation, renal impairment, coronary artery disease, and others. By route of administration, the market can be divided into intravenous, and subcutaneous. The end userscovered in the study includehospitals, clinics, homecare setting, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

The report provides a comprehensive analysis of the key players of the heparin market including Aspen Holdings, Baxter International Inc., B. Braun Melsungen AG, Dr. Reddy’s Laboratory Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Novartis International AG (Sandoz), Pfizer Inc., Sanofi S.A., and Teva Pharmaceutical Industries Ltd. Other players in the value chain include Leo Pharma A/S, Hospira, Inc., Mylan Institutional LLC, Cardinal Health, Aurobindo Pharma Limited, and others. 

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current heparin market trends and futureestimations from 2019 to 2026, which assists to identify the prevailing heparin market opportunities. 

  • An in-depth market analysis includes various countries, and is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate country-specific plans.

  • A comprehensive analysis of the factors that drives and restrains the growth of the global heparin market is provided.

  • Region-wise market conditions are comprehensively analyzed in this report.

  • An extensive analysis of various countries provides insights that are expected to allow companies to strategically plan their business moves.

  • Key market players within the heparin market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of global heparin market.  

Key Segmentation:

By Product

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)


By Source 

  • Bovine
  • Porcine

By Application

  • Venous Thromboembolism
  • Atrial Fibrillation
  • Renal Impairment
  • Coronary Artery Disease
  • Others

By Route of Administration

  • Intravenous
  • Subcutaneous

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Start reading ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at










Purchase Full Report of
Heparin Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $8,995  $8,096
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts